ArticleAnnals of translational medicine2021

Combination of pembrolizumab plus temozolomide therapy in unresectable and advanced melanoma: a multicenter retrospective analysis in China.

Tu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.